STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (36,700,681)	$ (36,361,109)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	3,828,917	2,231,108
Non-cash lease expense	54,469	31,441
Share-based payments for services	762,261	1,226,690
Equity-based compensation	11,389,932	13,685,046
Common stock contributed to 401(k) plan	223,043	201,099
Gain on short term investments	(615)	(5,621)
(Gain) loss on derivative instruments	(366,791)	694,858
Modification of warrants	0	24,387
Impairment loss on abandonment of patents	30,793	0
(Increase)/decrease in assets:
Receivables	54,922	0
Prepaid expenses	167,651	283,964
Supplies used for R&D and manufacturing	(159,430)	(1,186,532)
Deposits	1,910,917	(240,000)
Increase/(decrease) in liabilities:
Accounts payable	374,890	445,981
Accrued expenses	(16,724)	363,701
Due to employees	205,495	(182,029)
Net cash used in operating activities	(18,240,951)	(18,787,016)
CASH FLOWS FROM INVESTING ACTIVITIES:
Net sales (purchases) of US Treasury bills	6,152,000	(6,145,764)
Purchases of property and equipment	(637,892)	(9,016,329)
Expenditures for patent costs	(22,741)	(22,641)
Net cash provided by (used in) investing activities	5,491,367	(15,184,734)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock and warrants	0	47,363,426
Payment of share issuance costs	(169,445)	(325,034)
Proceeds from the exercise of warrants	101,225	5,984,215
Proceeds from the exercise of options	29,835	746,228
Proceeds from the purchase of stock by officers and directors	0	220,000
Proceeds from landlord funding of lease improvements	786,454	1,613,546
Payments on obligations under finance leases	(1,386,495)	(1,079,392)
Net cash (used in) provided by financing activities	(638,426)	54,522,989
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS	(13,388,010)	20,551,239
CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR	36,060,148	15,508,909
CASH AND CASH EQUIVALENTS, END OF YEAR	22,672,138	36,060,148
SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Property and equipment included in accrued expenses and accounts payable	0	435,412
Capitalizable patent costs included in accrued expenses and accounts payable	0	6,510
Changes to right of use assets and liabilities	16,268	551,444
Finance lease obligation included in accounts payable	1,354	855
Prepaid consulting services paid with issuance of common stock	295,143	363,911
Fair value of warrant liabilities on date of exercise	70,589	4,023,091
Assets purchased under finance leases	32,409	0
Financing costs included in current liabilities	9,010	0
Accrued consulting services to be paid with common stock	55,000	55,000
SUPPLEMENTAL DISCLOSURE OF CASH FLOWS:
Cash paid for interest	$ 1,157,069	$ 1,173,702